test

Glenn Shepard

@Suvretta Capital Management, Llc

Latest period2024 - Q3ReportedManaged Assets$3.125BTotal holdings98
Assets growth rate14.81%Assets growth rate (2-Q avg)7.96%Continuous growth in asset value4 quarters

Portfolio positions

This chart displays the top 10 holdings in Suvretta Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 98 positions.

Assets under management

The assets under management (AUM) of Suvretta Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.125B in assets, with a quarterly growth rate of 14.81% and a 2-quarter average growth rate of 7.96%. The portfolio is managed by Glenn Shepard, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SPYSpdr S&p 500 Etf Tr
Recent Activity
Increased 10%
10.1%
$315.568M↓ Put
550,000 shares@ $573.76 avg price
BHVNBiohaven Ltd
Recent Activity
8.32%
$259.805M
5.199M shares@ $49.97 avg price
KURAKura Oncology Inc
Recent Activity
Increased 8.25%
4.79%
$149.535M
7.653M shares@ $19.54 avg price
INSMInsmed Inc
Recent Activity
Decreased -35.13%
3.83%
$119.407M
1.636M shares@ $73.0 avg price
ITCIIntra-cellular Therapies Inc
Recent Activity
Decreased -8.1%
3.37%
$105.294M
1.439M shares@ $73.17 avg price
ARQTArcutis Biotherapeutics Inc
Recent Activity
Increased 7.17%
3.2%
$99.71M
10.722M shares@ $9.3 avg price
METAMeta Platforms Inc
Recent Activity
Increased 0.79%
3.09%
$96.449M
168,488 shares@ $572.45 avg price
UNHUnitedhealth Group Inc
Recent Activity
Decreased -9.05%
2.75%
$85.857M
146,845 shares@ $584.69 avg price
BNTCBenitec Biopharma Inc
Recent Activity
Increased 422.04%
2.6%
$81.139M
8.829M shares@ $9.19 avg price
AAPLApple Inc
Recent Activity
Decreased -7.48%
2.51%
$78.322M
336,147 shares@ $233.0 avg price